CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies (Q71692478)
Jump to navigation
Jump to search
scientific article published on 01 October 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies |
scientific article published on 01 October 1996 |
Statements
CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies (English)
Mavroudis D
Read E
Cottler-Fox M
Couriel D
Molldrem J
Carter C
Yu M
1 October 1996